Elicera Therapeutics AB(SE:ELIC)
kr 2.60+0.00 (+0.19%)
SE:ELIC
Elicera Therapeutics AB financials statements
kr 2.60
At close:+0.00 (+0.19%)
Want to see SE:ELIC full AI Analyst Report?
Elicera Therapeutics AB (ELIC) Income Statement
3 Followers
Elicera Therapeutics AB Income Statement
Last quarter (Q2 2026), Elicera Therapeutics AB's total revenue was kr-147.66K, a decrease of 105.48% from the same quarter last year. In Q2, Elicera Therapeutics AB's net income was kr-6.26M. See Elicera Therapeutics AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 0.00 | kr 7.13M | kr 11.23M | kr 1.28M | kr 587.00 | |
| kr 0.00 | kr 7.13M | kr 11.22M | kr 1.28M | kr -11.19K | |
| kr 17.94M | kr 24.01M | kr 28.33M | kr 20.64M | kr 13.12M | |
| Depreciation and Amortization | kr 0.00 | kr 11.78K | kr 11.77K | kr 11.79K | kr 11.78K |
| kr -17.40M | kr -16.87M | kr -17.08M | kr -19.43M | kr -13.11M | |
| kr -17.94M | kr -16.88M | kr -28.33M | kr -19.36M | kr -13.12M | |
| kr 538.02K | kr 773.73K | kr 11.93M | kr -75.88K | kr -1.07K | |
| kr -17.41M | kr -16.11M | kr -16.40M | kr -19.44M | kr -13.12M | |
| kr -17.41M | kr -16.11M | kr -16.40M | kr -19.52M | kr -13.12M | |
| Per Share Metrics | |||||
| Basic EPS | kr -0.38 | kr -0.51 | kr -0.83 | kr -0.98 | kr -0.82 |
| Diluted EPS | kr -0.37 | kr -0.51 | kr -0.83 | kr -0.98 | kr -0.82 |
| Weighted Average Shares Outstanding | 45.58M | 31.57M | 19.78M | 19.78M | 15.94M |
| Weighted Average Shares Outstanding (Diluted) | 48.19M | 31.57M | 19.78M | 19.78M | 15.94M |
Currency in SEK
